Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Drugs
1 - 20 of 1,298 Results
-
-
At a Tennessee Hospital, a Nurse Stole Fentanyl and AI Missed It, State Records Say
Sentri7, drug diversion software powered by artificial intelligence and used at hundreds of U.S. hospitals, did not catch a months-long string of fentanyl thefts in Tennessee in 2025, according to a state document.
By Brett Kelman and Darius Tahir -
Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients. “It gives a black eye to telemedicine,” one researcher said.
By Lauren Sausser and Maia Rosenfeld -
Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Darius Tahir -
Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
The data behind alcohol-related traffic deaths is well studied. Less understood is the toll of vehicle deaths involving drugs or a combination of drugs and alcohol. Attempts to fix that have been stymied by federal budget and staffing cuts.
By Jace DiCola -
Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
By Darius Tahir -
Journalists Unpack Latest on Vaccines, Vaping, and TrumpRx
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
-
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
By Arthur Allen -
That Discount at the Pharmacy Counter May Pack Hidden Costs
The new TrumpRx program relies partly on connecting consumers with discount coupons offered by drugmakers. For insured patients, though, using a coupon can prove dicey.
-
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
For all of President Donald Trump’s showmanship, the share of Americans his policies will likely help remains slim, even if some patients do come out ahead.
By Elisabeth Rosenthal and Arthur Allen -
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
It may soon get easier for millions of people with Medicare to get discounted GLP-1 drugs for weight loss.
The Supreme Court Case That Could Slow Generic Drugs
Season 15, Episode 6In “Hikma v. Amarin,” the Supreme Court’s decision could affect how quickly generic versions of brand-name medicines come to market.
The Accidental Architect of America’s Drug Patent Problem
Season 15, Episode 5An Arm and a Leg launches its “101” series with the story of Alfred Engelberg, a lawyer who’s been crusading to improve access to generic drugs by fixing loopholes in a law he helped draft more than 40 years ago.
-
Journalists Capsulize Weight Loss News and ACA Premium Pressures
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
-
Readers Sound Off on Wage Garnishment, Work Requirements, and More
KFF Health News gives readers a chance to comment on a recent batch of stories.
-
Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
So you’ve decided to go on a GLP-1 to lose weight. These medicines might seem like an easy way to drop unwanted pounds, but you’ll likely need to do a few other things to be successful long-term.
-
Maker of Device To Treat Addiction Withdrawal Seeks Counties’ Opioid Settlement Cash
Some researchers and recovery advocates see the NET device as the latest in a series of products pitched as the solution to the addiction crisis that have been overhyped to capitalize on money from the opioid settlements.
RFK Jr.’s Very Bad Week
Episode 437HHS Secretary Robert F. Kennedy Jr. had another tough week. In addition to Kennedy having rotator cuff surgery, the nomination of his ally to become surgeon general is teetering, the controversial head of the FDA's vaccine center is resigning next month, and a new survey shows Americans trust government health officials less than they do former Biden official Anthony Fauci. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more.
-
He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
Diagnosed with an autoimmune disorder, a California man was prescribed a drug that costs thousands of dollars a month. He said he was reassured that the drugmaker’s copay card would cover his share, but after two months, the card was empty.
-
As More Americans Embrace Anxiety Treatment, MAHA Derides Medications
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, claiming they’re harmful. Doctors and researchers say the MAHA movement is misrepresenting drugs that have been proved to safely treat chronic anxiety and point to broader social changes to explain their increased use.